Optimal management of patients with non-ulcer dyspepsia: Considerations for the treatment of the elderly

Drugs and Aging

Volumn 18, Issue 11, 2001, Pages 819-826

  Asante, Maxwell A ^a  

^a Bromley Hospitals NHS Trust   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CISAPRIDE; CYTOCHROME P450 3A4; HISTAMINE H2 RECEPTOR ANTAGONIST; PROKINETIC AGENT; PROTON PUMP INHIBITOR; SIMETHICONE;

AGED; CONSTIPATION; DYSPEPSIA; HEART ARRHYTHMIA; HELICOBACTER PYLORI; HUMAN; INTESTINE MOTILITY; PRIORITY JOURNAL; REVIEW; SOCIAL PSYCHOLOGY;

EID: 0035692743     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200118110-00003     Document Type: Review

References (69)

1. Dyspepsia in England and Scotland
2. A survey of dyspepsia in Great Britain
3. A critique of therapeutic trials in Helicobacter pylori positive functional dyspepsia
4. Management of dyspepsia: Report of a working party
5. Gastroesophageal reflux disease. Scintigraphic, endoscopic and histologic considerations
6. Are esophageal symptoms reflux-related?. A study of different scoring systems in a cohort of patients with heartburn
7. Functional gastroduodenal disorders
8. Geographical differences in the prevalence of dyspepsia
9. Dyspepsia: Organic causes and differential characteristics from functional dyspepsia
10. Do young patients with dyspepsia need investigation?
11. Open-access upper alimentary endoscopy
12. Screening dyspepsia by serology to Helicobacter pylori
13. Etiology of dyspepsia: Four hundred unselected consecutive patients in general practice
14. Diagnostic methods in dyspepsia: The usefulness of upper abdominal ultrasound and gastroscopy
15. Nonsteroidal anti-inflammatory, drugs and dyspepsia in the elderly
16. Gastrointestinal side-effects of NSAIDs in the community
17. Dyspepsia and dyspepsia subgroups: A population-based study
18. Manometric evaluation of functional upper gut symptoms
19. Evidence for hypomotility in non-ulcer dyspepsia: A prospective multifactorial study
20. Gastroparesis of digestible and indigestible solids in patients with insulin-dependent diabetes mellitus or functional dyspepsia
21. Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride
22. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia
23. Role of impaired gastric accommodation to a meal in functional dyspepsia
24. Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia. The irritable stomach syndrome
25. Symptoms and visceral perception in severe functional and organic dyspepsia
26. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients
27. The origin of symptoms on the brain-gut axis in functional dyspepsia
28. Nonulcer dyspepsia associated with psychiatric disorder
29. Factors affecting the decision to consult with dyspepsia: Comparison of consulters and non-consulters
30. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia
31. Functional dyspepsia. Insights on mechanisms and management strategies
32. Psychotherapy in functional dyspepsia
33. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori
34. Cure of duodenal ulcer associated with eradication of Helicobacter pylori
35. Helicobacter pylori in peptic ulcer disease
36. The role of Helicobacter pylori in nonulcer dyspepsia. A debate for
37. Helicobacter pylori in functional dyspepsia and normal controls
38. Prevalence of Helicobacter pylori infection and chronic dyspeptic symptoms among immigrants from developing countries and people born in industrialized countries
39. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia
40. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia
41. Lack of effect of treating Helicobacter pylori infection in patients with non-ulcer dyspepsia
42. Is Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms?. A meta-analysis
43. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia
44. Treatment with cimetidine, antacid, or placebo in patients with dyspepsia of unknown origin
45. Controlled clinical trial of treatment with cimetidine for non-ulcer dyspepsia
46. Effect of cimetidine in patients with non-ulcer dyspepsia and erosive prepyloric changes
47. Cimetidine in the treatment of non-ulcer dyspepsia: Results of a randomized double-blind, placebo-controlled study
48. Dyspepsia: Incidence of a non-ulcer disease in a controlled trial of ranitidine in general practice
49. Pharmacological interventions for non-ulcer dyspepsia
50. Cisapride in chronic dyspepsia: Results of a double-blind, placebo-controlled trial
51. Efficacy of cisapride therapy in functional dyspepsia
52. Effect of cisapride on functional dyspepsia in patients with and without histological gastritis: A double-blind placebo-controlled trial
53. A double-blind, randomized, placebo-controlled trial of cisapride in Saudi Arabs with functional dyspepsia
54. Prolongation of the QT interval related to cisapride-diltiazem interaction
55. Syncopal episodes associated with cisapride and concurrent drugs
56. Torsade de pointes induced by cisapride/clarithromycin interaction
57. The risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada
58. Domperidone in the treatment of functional dyspepsia in patients with delayed gastric emptying
59. Efficacy of omeprazole in functional dyspepsia: Double-blind, randomized, placebo-controlled trials (the Bond and Opera studies)
60. Randomised double-blind comparison of simethicone with cisapride in functional dyspepsia
61. Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia
62. A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin
63. Gastroduodenal problems associated with non-steroidal, anti-inflammatory drugs (NSAIDs)
64. Upper gastrointestinal motor activity in patients with slow-transit constipation. Further evidence for an enteric neuropathy